Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 1993 / Article

Open Access

Volume 4 |Article ID 137626 | https://doi.org/10.1155/1993/137626

Paul D Griffiths, "Cytomegalovirus and Human Herpesvirus 6 and 7: Diseases and Diagnosis in Transplantation", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 4, Article ID 137626, 7 pages, 1993. https://doi.org/10.1155/1993/137626

Cytomegalovirus and Human Herpesvirus 6 and 7: Diseases and Diagnosis in Transplantation

Abstract

Similarities and differences in the epidemiology of cytomegalovirus (CMV), human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) infections are reviewed. Several distinct laboratory methods have been described for each virus. For CMV in immunocompromised patients, infection is best diagnosed by identifying active infection using routine surveillance cultures. Patients with active infection can then be entered into trials of suppressive therapy (where virus excretion is from the urine or saliva) or pre-emptive therapy (where excretion is detected systemically). For HHV-6 and HHV-7, only anecdotal cases of associations with disease in immunocompromised patients have been reported. Recommendations cannot therefore be made about appropriate diagnostic strategies or about treatment since it is not clear if these viruses are pathogens or passengers.

Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views33
Downloads216
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.